Funding profile · Maternal and infant nutrition

BBy

A $3 million seed round, announced in May 2023 after seven bootstrapped years, is the only funding this company has publicly reported. No SEC filing for that round, or for any other BBy financing, turned up in the searches run for this page.

$3.0MSeed round announced May 2023, company-reported
$500K+From Y Combinator alumni angels, part of the same round, company-reported
7Years bootstrapped before the first announced outside money, per Femtech Insider
0SEC Form D filings found naming BBy, Inc. or a related entity

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2016 to 2022 Y Combinator, Winter 2022 batch Not disclosed Y Combinator Company
Bootstrapped Self-funded, seven years Not disclosed Founders Independent
May 2023 Seed, announced $3.0M Led by Pioneer Fund; Y Combinator, 7G Bioventures, Cathexis Ventures, YC alumni angels (over $500K) Company release

What the filings show

No SEC Form D naming BBy, Inc., or any entity referencing BBy, appears in the sources checked for this page, and none was returned by the automated federal filing search run before this profile was built. That is a gap worth naming plainly: it does not prove the May 2023 seed round never happened, since companies raising under some exemptions to Regulation D, or through certain private placements, do not always generate a Form D that is easy to find, and a filing could exist under a legal entity name that does not resemble the brand. But for a $3 million round with four named institutional participants, the absence of any matching SEC record is notable, and no filing has been found to confirm the amount, the investors, or the date the company itself has publicized.

Reading the announcement

  1. The number comes from one moment, one press cycle.Every figure on this page traces back to a single coordinated announcement in the week of May 25, 2023, carried by TechCrunch, Crunchbase News, Femtech Insider, Research & Development World, New Atlas and a company-issued release on Yahoo Finance. All of them cite the company as the source for the $3 million figure and the investor list. No outlet reported independently verifying the amount against a filing.
  2. Seven bootstrapped years is itself a data point.Femtech Insider reported the company operated without institutional capital from its founding until this round, meaning $3 million plus roughly $500,000 in alumni angel money is the entire disclosed capital base for a company that, per its own 2023 statement to TechCrunch, was running at close to $10 million in annualized revenue.
  3. No later round has been announced.No source reviewed for this page reports a Series A, a bridge, or any additional financing after the May 2023 seed. Whether that reflects continued bootstrapping off revenue, an unannounced raise, or a stall is not something the public record answers.
  4. The revenue claim, if accurate, would make outside financing look modest.Langer told TechCrunch in 2023 that BBy was averaging about $800,000 a month in revenue. If that figure held, it would put BBy’s reported outside capital at well under half of one year’s revenue, an unusually thin capital base for a hospital-contract business with the long sales cycles Langer himself described in the same interview.

Commercial signals

Signal Detail Source type
Revenue Company said it was averaging about $800,000 a month, approaching $10 million annualized, as of May 2023. Not independently verified, and no later figure has been reported. Company-stated
Customers 17 client hospitals in Massachusetts, Connecticut and Texas as of May 2023; over 20 hospitals in New York, New Jersey and Connecticut described from 2024 onward. No hospital has been named in any source reviewed. Company-stated
Pricing model Company told The Hustle it prices contracts at roughly 10 percent of a hospital’s projected labor savings, estimated from NICU nursing headcount. Company-stated
Regulatory Company says the FDA classified its device as a food device requiring no further medical review. No FDA record confirming this was found. Not found
Competitive set Crunchbase News covered BBy alongside consumer-facing competitors including Milkify, which uses freeze drying and markets directly to parents rather than hospitals, and appeared on Shark Tank the month before BBy’s funding announcement. Independent

What to watch

  • Any SEC Form D that surfaces for BBy, Inc. or a related fundraising entity, which would let the company’s own numbers be checked against a filed record.
  • A Series A or other follow-on round, none of which has been reported since the May 2023 seed.
  • Independent confirmation of the reported $800,000-a-month revenue figure.
  • Named hospital customers, which would let the reported footprint be checked directly.

The BBy story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Kilobaser: Shared investor: Cathexis Ventures. A Graz, Austria company that built a benchtop machine for printing short DNA and RNA strands in a lab, instead of ordering them from a central supplier
  • Recover: Shared investor: Cathexis Ventures. A California outpatient addiction treatment provider, paid mostly by county governments, that began as a telehealth service and now holds eight state certifications for
  • Invert: Shared investor: Cathexis Ventures. Software that pulls data off bioreactors and analytical instruments, harmonizes it, and since October 2025 answers questions about it in plain language
  • Craniometrix: Shared investor: Cathexis Ventures. A New York company that set out to catch Alzheimer’s early with a phone game and now runs dementia care navigation paid for by Medicare

Sources

  1. IndependentBBy device turns breast milk into powder, helps NICU nurses avoid lengthy ‘milk shift’TechCrunch, Christine Hall · May 25, 2023
  2. IndependentPowdered Breast Milk Startups Are A Thing And This One Just Grabbed $3M In FundingCrunchbase News, Keerthi Vedantam · May 25, 2023
  3. IndependentNew York-based BBy Raises $3M in Seed Funding to Reinvent Breast Milk Management in HospitalsFemtech Insider · May 29, 2023
  4. IndependentBBy creates first condensed-to-powder breast milk, announces seed fundingResearch & Development World, Heather Hall · May 25, 2023
  5. Independent“Game-changing” BBy tech keeps essential nutrients in powdered breast milkNew Atlas, Ben Coxworth · May 25, 2023
  6. IndependentGot Milk? This Healthtech Startup Makes Powdered Breast Milk for Vulnerable BabiesThe Hustle, Sara Friedman · Apr 7, 2024
  7. CompanyBBy Creates First Condensed-to-Powder Breast Milk, Maintaining All Bioactive and Immune Factors; Announces Seed FundingYahoo Finance / ACCESSWIRE · May 25, 2023
  8. IndependentBBy, Inc. company profileCrunchbase · archived Nov 30, 2023
  9. CompanyBBy, Inc. profileGust, accessed Sep 25, 2026
  10. CompanyBBy company pageY Combinator, accessed Sep 25, 2026

Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in BBy. This page is not an offer to sell or a recommendation to buy any security.